arrow
P

Philip G. Conaghan

University of Leeds
H指数:116
被引数:5.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of the TRPV1 agonist RTX-GRT7039 in patients with pain associated with knee osteoarthritis: results from a phase 3, randomised, placebo-controlled trial

TRPV1激动剂RTX-GRT7039在膝关节骨关节炎疼痛患者中的疗效与安全性:一项Ⅲ期、随机、安慰剂对照试验的结果

2026-10-220
PRE
International Imaging Practices for Sacroiliac Joint MRI Acquisition Protocols in Patients with Juvenile Spondylarthritis

国际青少年脊柱关节炎患者骶髂关节MRI采集方案成像实践

2026-09-030
OA
DNA hypo-methylation of the TNFA gene predicts response to MTX in RA but not in PsA

肿瘤坏死因子α基因低甲基化可预测类风湿关节炎对甲氨蝶呤的应答,但无法预测银屑病关节炎的应答

2026-08-280
PRE
Exploring clusters based on ultrasound-detected inflammation in patients with psoriatic arthritis: a post-hoc analysis from the ULTIMATE trial

基于超声检测的炎症探索银屑病关节炎患者的聚类:ULTIMATE试验的事后分析

2026-01-300
PRE
A prospective, open-label, clinical investigation of a single intra-articular polyacrylamide hydrogel injection in participants with knee osteoarthritis: a 5-year extension study

一项前瞻性、开放标签的临床研究,评估单次关节内聚丙烯酰胺水凝胶注射在膝骨关节炎受试者中的疗效:一项5年扩展研究

2025-12-120
OAAI
Novel approaches to the stratified management of knee osteoarthritis

分层管理膝关节骨关节炎的新方法

2025-10-030
PRE
A randomised controlled Phase II trial of LEVI-04, a novel neurotrophin-3 inhibitor, in knee osteoarthritis demonstrates substantially improved pain and function without deleterious effects on joint structure

一项关于LEVI-04(一种新型神经营养因子-3抑制剂)的随机对照II期临床试验,在膝关节骨关节炎患者中证实了疼痛和功能的显著改善,且对关节结构无不良影响。

2025-04-280
PRE
Intra-articular MM-II for the treatment of knee osteoarthritis pain: Efficacy and safety results from a 26-week, phase 2b, placebo-controlled, double-blind, randomized dose-ranging trial

关节内MM-II治疗膝关节骨关节炎疼痛:一项为期26周的2b期、安慰剂对照、双盲、随机剂量范围试验的疗效和安全性结果

2025-04-230
OAAI